pharma


Also found in: Dictionary, Medical, Wikipedia.
Related to pharma: Big pharma
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Synonyms for pharma

a company that makes and sells pharmaceuticals

References in periodicals archive ?
This is a promising drug with the potential to address at least two areas of unmet medical need" comments Lars Ekman, MD, PhD, member of the Board for Schwarz Pharma AG.
MGI PHARMA markets Aloxi([R]) (palonosetron hydrochloride) Injection, Dacogen([R]) (decitabine) for Injection, and Gliadel([R]) Wafer (polifeprosan 20 with carmustine implant) in the United States.
integrated Pharma Technologies (iPT), and Q Logistics, Inc.
Financial and Strategic Analysis of the Sales Outlook to 2011 for Big Pharma, Mid Pharma, Japan Pharma and Biotech
At this point, type in Nutra Pharma or its ticker symbol, "NPHC," and you will be directed to the interview.
MGI PHARMA markets Aloxi[R] (palonosetron hydrochloride) Injection, Dacogen[TM] (decitabine) for Injection and Gliadel[R] Wafer (polifeprosan 20 with carmustine implant) in the United States.
Under the agreement terms, Alfacell grants exclusive marketing and distribution rights for ONCONASE to GENESIS Pharma S.
Based on these results, HELSINN and MGI PHARMA plan for the submission of a Supplemental New Drug Application (sNDA) to the U.
The world's leading drug discovery and development technologies and approaches will be showcased at the Molecular Medicine Tri-Conference," says Pharma DD Editor-in-Chief Malorye A.
SCOLR Pharma said it expects additional CDT-based product introductions by Perrigo in the coming year.
IDM Pharma is a biopharmaceutical company focused on the development of innovative products that activate the immune system to treat cancer.
Nutra Pharma is currently developing breakthrough scientific treatments for MS, HIV/AIDS, and Adrenomyeloneuropathy (AMN) using modified cobra venom and cobratoxin.
STOCKHOLM, Sweden -- Action Pharma A/S has received venture capital to assure rapid development of the company's pipeline of novel pharmaceuticals targeted at several major indications.
Based upon the FDA's request, we will be evaluating options to maximize the value of Saforis," said Lonnie Moulder, President and CEO of MGI PHARMA.